NOVEL HCV INHIBITOR COMBINATIONS AND METHODS

摘要

Novel hepatitis C virus ("HCV") inhibitor combinations comprising an HCV protease inhibitor and HCV polymerase inhibitor, and optionally one or more biologically active agents, as well as uses of these combinations as HCV inhibitors and for treating hepatitis C and related disorders are disclosed.